共查询到20条相似文献,搜索用时 62 毫秒
1.
C. Lázaro Antonia Gaona Peter Ainsworth Romano Tenconi Dominique Vidaud Helena Kruyer Elisabet Ars Víctor Volpini Xavier Estivill 《Human genetics》1996,98(6):696-699
Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder with a prevalence of around 1 in 3500, affecting all ethnic
groups. The clinical manifestations of the disease are variable, even among members of the same family, and affect a variety
of tissues and cell types, including skin, iris, central and peripheral nervous systems and skeletal system. It has been reported
that the majority of sporadic mutations in NF1 arise in paternally inherited alleles. We present here a collaborative study
of the parental origin and type of mutation in individuals with de novo NF1, who account for up to a half of all cases of
clinically diagnosed NF1. We have studied intragenic and extragenic markers in 470 NF1 families. In 32 of these families it
was possible to assess the parental origin of a de novo NF1 mutation either by linkage analysis (in families with three generations) or by the detection of an intragenic deletion in
a sporadic NF1 case. Eleven of these 32 families have three generations (the second and third generation being affected),
with the mutation (not a large deletion) being of paternal origin in 82% of them (P < 0.05). In the other 21 families an intragenic deletion was detected, in 76% being in the maternal chromosome and in 24%
in the paternal one (P < 0.05). Our results suggest that in NF1 the majority of deletions occur in oogenesis, while other types of mutations should
account for the paternally derived NF1 mutations.
Received: 26 June 1996 / Revised: 1 August 1996 相似文献
2.
Peter N. Robinson Annett Böddrich Hartmut Peters Sigrid Tinschert Annegret Buske Dieter Kaufmann Peter Nürnberg 《Human genetics》1995,96(1):95-98
We screened a total of 92 unrelated patients with neurofibromatosis type 1 (NF1) for mutations in exon 37 of the NF1 gene, by using temperature gradient gel electrophoresis. Two novel mutations were found: a 4 bp deletion in a so-called quasi-symmetric element (6789delTTAC) and a recurrent nonsense mutation, which was identified in two unrelated patients, at codon 2264 (C6792A). The independent origin of the latter mutation in two families was confirmed by haplotype analysis. The nonsense mutation and the 4 bp deletion are both predicted to lead to a truncated protein product lacking the Cterminal 20% (aproximately) of its sequence. The occurrence of three independent mutations among 92 NF1 patients at codons 2263–2264 (exon 37) suggests that a specific search for mutations in this area should be undertaken in screening programs for NF1 mutations. 相似文献
3.
4.
Anja Klose Peter Nicholas Robinson Andreas Gewies Lan Kluwe Dieter Kaufmann Annegret Buske Sigrid Tinschert H. Peters 《Human genetics》1998,102(3):367-371
Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder. It is caused by mutations in the NF1 gene, which comprises
60 exons and is located on chromosome 17q11.2. A total of 170 unrelated NF1 patients were screened for mutations in four exons
by temperature-gradient gel electrophoresis. Preparatory work revealed the presence of a previously uncharacterized intron
(19a) in what was previously designated exon 19; this allowed us to develop assays for genomic mutation screening in the newly
defined exons 19a and 19b. Two novel NF1 mutations were detected: a single-base insertion in exon 19a creating a frameshift,
and a second mutation affecting the splice donor site of intron 20 and leading to skipping of exon 20. A novel BsaBI polymorphism was identified in intron 19a.
Received: 11 August 1997 / Accepted: 13 November 1997 相似文献
5.
Karen Stephens Lucille Kayes Vincent M. Riccardi Marcia Rising Virginia P. Sybert Roberta A. Pagon 《Human genetics》1992,88(3):279-282
Summary An interesting feature of neurofibromatosis type 1 (NF1) is its high mutation rate of 1×10–4 per gamete per generation. The molecular basis for frequent NF1 mutation in unknown; the gene is not deletion prone. We have found that in all ten families examined, the apparent new NF1 mutation occurred on the paternally-derived chromosome. The probability of observing this result by chance is less than 0.001 assuming an equal frequency of mutation of paternal and maternal NF1 genes. We hypothesize a role for genomic imprinting that may either enhance mutation of the paternal NF1 gene or confer protection from mutation to the maternal NF1 gene. 相似文献
6.
Neurofibromatosis 2 (NF2) is a clinically variable autosomal dominant disorder, caused by mutations in the NF2 tumor suppressor gene on chromosome 22q12, that predisposes to nervous system tumors and ocular abnormalities. To assess intrafamilial
phenotypic variability, we performed mutation analysis and clinical assessment on two multigeneration NF2 families with five
patients and seven asymptomatic first-degree relatives of patients. One family had a point mutation of agCC→ggCC at position
1447–2 at the exon 13/14 boundary predicted to lead to an altered splice acceptor sequence and exon deletion. The other family
had an insertion of 2 base pairs (TC) at position 761 in exon 8, leading to a frameshift. Both mild and severe phenotypes
occurred in each family, indicating that phenotypic variability in NF2 can be caused by factors other than NF2 mutations. Genetic counseling of NF2 families should include the possibility that presymptomatic NF2 mutation carriers can develop a different phenotype than previously diagnosed patients.
Received: 4 January 1996 / Revised: 26 March 1996 相似文献
7.
Cong-Yi Wang Abdoreza Davoodi-Semiromi W. Huang Ellen Connor Jing-Da Shi J.-X. She 《Human genetics》1998,103(6):681-685
Autoimmune polyglandular syndrome type 1 (APS1), also known as autoimmune polyendocrinopathy candidiasis ectodermal dystrophy
(APECED), is an autosomal recessive disorder characterized by the failure of several endocrine glands as well as nonendocrine
organs. The autoimmune regulator (AIRE) gene responsible for APS1 on chromosome 21q22.3 has recently been identified. Here, we have characterized mutations in the
AIRE gene by direct DNA sequencing in 16 unrelated APS1 families ascertained mainly from the USA. Our analyses identified four
different mutations (a 13-bp deletion, a 2-bp insertion, one nonsense mutation, and one potential splice/donor site mutation)
that are likely to be pathogenic. Fifty-six percent (9/16) of the patients contained at least one copy of a 13-bp deletion
(1094–1106del) in exon 8 (seven homozygotes and two compound heterozygotes). A nonsense mutation (R257X) in exon 6 was also
found in 31.3% (5/16) of the USA patients. These data are important for genetic diagnosis and counseling for families with
autoimmune endocrine syndromes.
Received: 24 August 1998 / Accepted: 29 September 1998 相似文献
8.
Bai-Lin Wu Richard G. Boles Hana Yaari Stanislawa Weremowicz Gretchen H. Schneider B. R. Korf 《Human genetics》1997,99(2):209-213
We report a young child with a large congenital cervical plexiform neurofibroma and multiple café-au-lait spots in a generalized
distribution who has mosaicism for complete deletion of the NF1 gene. The deletion was demonstrated with intragenic cosmid probes as well as YACs spanning a 700-kb contig including NF1, by two-color FISH with an NF1 and a control probe. Using different intragenic probes, deletion was found in 77–84% of cultured peripheral blood lymphocytes
but not in cultured skin fibroblasts. Neither parent has signs of neurofibromatosis type 1 (NF1) or a gene deletion. This
is the first report of mosaicism for complete deletion of the NF1 gene. The child did not have typical NF1 or display segmental features of NF1.
Received: 6 June 1996 / Revised: 2 October 1996 相似文献
9.
Maria C. Pintao A. A. Garcia D. Borgel M. Alhenc-Gelas C. A. Spek M. C. H. de Visser S. Gandrille Pieter H. Reitsma 《Human genetics》2009,126(3):449-456
Hereditary protein S (PS) deficiency is an autosomal disorder caused by mutations in the PS gene (PROS1). Conventional PCR-based mutation detection identifies PROS1 point mutations in approximately 50% of the cases. To verify if gross copy number variations (CNVs) are often present in
point mutation-negative hereditary PS deficiency we used multiplex ligation-dependent probe amplification (MLPA) as a detection
tool in samples from individuals with a high probability of having true PS deficiency. To this end, DNA samples from nine
PS deficient probands with family members (seven type I and two type III) and nine isolated probands (three type I and six
type III), in whom PROS1 mutations were not found by DNA sequencing, were evaluated. An independent quantitative PCR (qPCR) was performed to confirm
the findings of the MLPA assay. Family members were also tested when DNA was available. Gross abnormalities of PROS1 were found in six out of eighteen probands. In three probands complete deletion of the gene was detected. Two probands had
a partial deletion involving different parts of the gene (one from exon 4 through 9 and another from exon 9 through 11). One
family showed a duplication of part of PROS1. qPCR analysis was in accordance with these results. In conclusion, this study substantiates that gross gene abnormalities
in PROS1 are relatively common in hereditary PS deficient patients and that MLPA is a useful tool for direct screening of CNVs in
PROS1 point mutation-negative individuals. 相似文献
10.
Meng H Hager K Held M Page GP Olson RK Pennington BF DeFries JC Smith SD Gruen JR 《Human genetics》2005,118(1):87-90
A candidate gene, EKN1, was recently described in a cohort from Finland for the dyslexia locus on chromosome 15q, DYX1. This report described a (2;15) (q11;21) translocation disrupting EKN1 that cosegregated with dyslexia in a two-generation family. It also characterized a sequence polymorphism in the 5′ untranslated region and a missense mutation that showed significant association in 109 dyslexics compared to 195 controls (p=0.002 and p=0.006, respectively). To confirm these results we interrogated the same polymorphisms in a cohort of 150 nuclear families with dyslexia ascertained through the Colorado Learning Disabilities Research Center. Using QTDT analysis with nine individual quantitative tasks and two composite measures of reading performance, we could not replicate the reported association. We conclude that the polymorphisms identified in the Finland sample are unlikely to be functional DNA changes contributing to dyslexia, and that if variation in EKN1 is causal such changes are more likely to be in regulatory regions that were not sequenced in this study. Alternatively, the published findings of association with markers in EKN1 may reflect linkage disequilibrium with variation in another gene(s) in the region. 相似文献
11.
Günther Weber Sean Grimmond Jacob Lagercrantz Eitan Friedman Catherine Phelan Emma Carson Nicholas Hayward Orit Jacobovitz Magnus Nordenskjöld Catharina Larsson 《Human genetics》1996,99(1):130-132
The predisposing genetic defect in multiple endocrine neoplasia type 1 has been assigned to chromosomal region 11q13. Our
previous attempts to identify the MEN1 gene have resulted in the isolation of the phospholipase Cβ3 gene from the actual region.
PLCB3 plays an important role in signal transduction and, moreover, shows loss of expression in some endocrine tumors, in accordance
with a putative tumor suppressor gene function, and thus appears to be an excellent candidate for MEN1. We have therefore
undertaken screening for constitutional mutations in individuals from MEN1 families. Several sequence alterations have been
discovered, none of them however fulfilling the criteria for a disease-related mutation. We can now exclude PLCB3 from candidacy as the MEN1 gene.
Received: 24 July 1996 / Revised: 16 August 1996 相似文献
12.
M. Glushkova I. Yordanova T. Todorov V. Bojinova M. Koleva P. Dimova I. Tournev L. Angelova A. Todorova V. Mitev 《Russian Journal of Genetics》2018,54(1):110-116
Neurofibromatosis (NF) is a clinically heterogeneous autosomal dominant disorder. Three distinct forms have been identified: neurofibromatosis type 1 (NF1), type 2 (NF2) and schwannomatosis. In the present study, we report clinical and genetic findings in the NF1 and NF2 genes in a cohort of 27 Bulgarian patients, with 18 cases (67%) genetically verified. Both NF1 and NF2 genes were screened by Sanger sequencing on DNA samples. The Sanger negative samples were screened by Multiplex Ligation-dependent Probe Amplification (MLPA) for deletions and duplications. The results from genetic testing revealed three novel mutations and fifteen previously reported ones (13 in the NF1 gene and 2 in the NF2 gene). The novel variants in the NF1 gene are a splice site mutation c.4725-1G>A, a small deletion of five bases c.823delATCTT, p.Leu275ValfsTer14, and a single base duplication c.6547dupC, p.Arg2183ProfsTer11. The novel splice site mutation is manifested by multiple “café au lait” macules and neurofibromas. Both novel out of frame mutations were found in patients with multiple “café au lait” spots and focal epilepsy. A segmental neurofibromatosis (SNF1) is restricted to one or more body segments. Here we present a case with SNF1 caused by a somatic deletion of exons 1 to 12 of the NF1 gene which is manifested by multiple neurofibromas in the right hand. Two nonsense mutations are found in the NF2 gene. Our study adds three novel mutations to the NF1 mutation spectra and contributes to the clinical-genetic NF1-characterization. Here we report strikingly different phenotypic spectra caused by the same mutation in a single family. Our findings contribute to the genotype- phenotype correlations which are difficult to establish, due to the extremely complex NF phenotype being a combination of clinical features. 相似文献
13.
High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene 总被引:9,自引:0,他引:9
下载免费PDF全文
![点击此处可从《American journal of human genetics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Kehrer-Sawatzki H Kluwe L Sandig C Kohn M Wimmer K Krammer U Peyrl A Jenne DE Hansmann I Mautner VF 《American journal of human genetics》2004,75(3):410-423
Detailed analyses of 20 patients with sporadic neurofibromatosis type 1 (NF1) microdeletions revealed an unexpected high frequency of somatic mosaicism (8/20 [40%]). This proportion of mosaic deletions is much higher than previously anticipated. Of these deletions, 16 were identified by a screen of unselected patients with NF1. None of the eight patients with mosaic deletions exhibited the mental retardation and facial dysmorphism usually associated with NF1 microdeletions. Our study demonstrates the importance of a general screening for NF1 deletions, regardless of a special phenotype, because of a high estimated number of otherwise undetected mosaic NF1 microdeletions. In patients with mosaicism, the proportion of cells with the deletion was 91%-100% in peripheral leukocytes but was much lower (51%-80%) in buccal smears or peripheral skin fibroblasts. Therefore, the analysis of other tissues than blood is recommended, to exclude mosaicism with normal cells in patients with NF1 microdeletions. Furthermore, our study reveals breakpoint heterogeneity. The classic 1.4-Mb deletion was found in 13 patients. These type I deletions encompass 14 genes and have breakpoints in the NF1 low-copy repeats. However, we identified a second major type of NF1 microdeletion, which spans 1.2 Mb and affects 13 genes. This type II deletion was found in 8 (38%) of 21 patients and is mediated by recombination between the JJAZ1 gene and its pseudogene. The JJAZ1 gene, which is completely deleted in patients with type I NF1 microdeletions and is disrupted in deletions of type II, is highly expressed in brain structures associated with learning and memory. Thus, its haploinsufficiency might contribute to mental impairment in patients with constitutional NF1 microdeletions. Conspicuously, seven of the eight mosaic deletions are of type II, whereas only one was a classic type I deletion. Therefore, the JJAZ1 gene is a preferred target of strand exchange during mitotic nonallelic homologous recombination. Although type I NF1 microdeletions occur by interchromosomal recombination during meiosis, our findings imply that type II deletions are mediated by intrachromosomal recombination during mitosis. Thus, NF1 microdeletions acquired during mitotic cell divisions differ from those occurring in meiosis and are caused by different mechanisms. 相似文献
14.
Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. 总被引:10,自引:4,他引:6
下载免费PDF全文
![点击此处可从《American journal of human genetics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
O. Johannsson E. A. Ostermeyer S. Hkansson L. S. Friedman U. Johansson G. Sellberg K. Brndum-Nielsen V. Sele H. Olsson M. C. King A. Borg 《American journal of human genetics》1996,58(3):441-450
Nine different germ-line mutations in the BRCA1 breast and ovarian cancer susceptibility gene were identified in 15 of 47 kindreds from southern Sweden, by use of SSCP and heteroduplex analysis of all exons and flanking intron region and by a protein-truncation test for exon 11, followed by direct sequencing. All but one of the mutations are predicted to give rise to premature translation termination and include seven frameshift insertions or deletions, a nonsense mutation, and a splice acceptor site mutation. The remaining mutation is a missense mutation (Cys61Gly) in the zinc-binding motif. Four novel Swedish founding mutations were identified: the nucleotide 2595 deletion A was found in five families, the C 1806 T nonsense mutation in three families, the 3166 insertion TGAGA in three families, and the nucleotide 1201 deletion 11 in two families. Analysis of the intragenic polymorphism D17S855 supports common origins of the mutations. Eleven of the 15 kindreds manifesting BRCA1 mutations were breast-ovarian cancer families, several of them with a predominant ovarian cancer phenotype. The set of 32 families in which no BRCA1 alterations were detected included 1 breast-ovarian cancer kindred manifesting clear linkage to the BRCA1 region and loss of the wild-type chromosome in associated tumors. Other tumor types found in BRCA1 mutation/haplotype carriers included prostatic, pancreas, skin, and lung cancer, a malignant melanoma, an oligodendroglioma, and a carcinosarcoma. In all, 12 of 16 kindreds manifesting BRCA1 mutation or linkage contained ovarian cancer, as compared with only 6 of the remaining 31 families (P<.001). The present study confirms the involvement of BRCA1 in disease predisposition for a subset of hereditary breast cancer families often characterized by ovarian cancers. 相似文献
15.
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. 总被引:71,自引:0,他引:71
D Viskochil A M Buchberg G Xu R M Cawthon J Stevens R K Wolff M Culver J C Carey N G Copeland N A Jenkins 《Cell》1990,62(1):187-192
Three new neurofibromatosis type 1 (NF1) mutations have been detected and characterized. Pulsed-field gel and Southern blot analyses reveal the mutations to be deletions of 190, 40, and 11 kb of DNA. The 11 kb deletion does not contain any of the previously characterized genes that lie between two NF1 translocation breakpoints, but it does include a portion of a rodent/human conserved DNA sequence previously shown to span one of the translocation breakpoints. By screening cDNA libraries with the conserved sequence, we identified a number of cDNA clones from the translocation breakpoint region (TBR), one of which hybridizes to an approximately 11 kb mRNA. The TBR gene crosses at least one of the chromosome 17 translocation breakpoints found in NF1 patients. Furthermore, the newly characterized NF1 deletions remove internal exons of the TBR gene. Although these mutations might act by compromising regulatory elements affecting some other gene, these findings strongly suggest that the TBR gene is the NF1 gene. 相似文献
16.
Jiahui Xia Duo Zheng Dongsheng Tang Heping Dai Qian Pan Zhigao Long Xiaodong Liao 《中国科学C辑(英文版)》2001,44(1):92-98
By homologous EST searching and nested PCR a new human geneGJB5 encoding gap junction protein β-5 was identified.GJB5 was genetically mapped to human chromosome 1p33-p35 by FISH. RT-PCR revealed that it was expressed in skin, placenta and fetal skin. DNA sequencing ofGJB5 was carried out in 142 patients with sensorineural hearing impairment and probands of 36 families with genetic diseases, including erythrokeratodermia (5 families), Charcot-Marie-Tooth disease (13), ptosis (4), and retinitis pigmentosa and deafness (14). Two missense mutations (686A→G, H229R; 25C→T, L9F) were detected in two sensorineural hearing impairment families. A heterologous deletion of 18 bp within intron was found in 3 families with heredity hearing impairment, and in one of the 3 families, a missense mutation (R265P) was identified also. But the deletion and missense mutation seemed not segregating with hearing impairment in the family. No abnormal mRNA or mRNA expression was detected in deletion carriers by RT-PCR analysis in skin tissue. Mutation analysis in 199 unaffected individuals revealed that two of them were carriers with the same 18 bp deletion. 相似文献
17.
L M Kayes W T Schroeder D A Marchuk F S Collins V M Riccardi M Duvic K Stephens 《Genomics》1992,14(2):369-376
Recently the M17S1 gene, encoding an epidermal antigen thought to play a role in cell adhesion, was mapped to chromosome bands 17q11-q12, placing it in the vicinity of the gene for the genetic disorder neurofibromatosis 1 (NF1). The pleomorphic cutaneous lesions of NF1 and the precedent for other genes being embedded within the NF1 gene prompted us to investigate whether the M17S1 gene mapped near, or within, the NF1 gene. Genetic linkage analyses revealed that M17S1 was tightly linked to NF1 and mapped within the interval bounded by D17S58 and D17S54. Physical mapping of an M17S1 cDNA on somatic cell hybrids, yeast artificial chromosomes, and an NF1 patient with a deletion involving an entire NF1 allele demonstrated that M17S1 is located at least 180 kb centromeric to the NF1 gene. The distance between the genes suggests that M17S1 is unlikely to contribute to the NF1 phenotype since a gross chromosomal rearrangement would be required to disrupt expression of both genes. 相似文献
18.
The achondroplasia gene is not linked to the locus for neurofibromatosis 1 on chromosome 17 总被引:1,自引:0,他引:1
S.-M. Pulst J. M. Graham Jr. P. Fain D. Barker T. Pribyl J. R. Korenberg 《Human genetics》1990,85(1):12-14
Summary We have investigated genetic linkage of von Recklinghausen neurofibromatosis (NF1) and achondroplasia (ACH) using chromosome-17 markers that are known to be linked to NF1. Physical proximity of the two loci was suggested by the report of a patient with mental retardation and the de novo occurrence of both NF1 and ACH. Since the chance of de novo occurrence of these two disorders in one individual is 1 in 600 million, this suggested a chromosomal deletion as a single unifying molecular event and also that the ACH and NF1 loci might be physically close. To test this, we performed linkage analysis on a three-generation family with ACH. We used seven DNA probes that are tightly linked to the NF1 locus, including DNA sequences that are known to flank the NF1 locus on the centromeric and telomeric side. We detected two recombinants between the ACH trait and markers flanking the NF1 locus. In one recombinant, the flanking markers themselves were nonrecombinant. Multi-point linkage analysis excluded the ACH locus from a region surrounding the NF1 locus that spans more than 15cM (lod score < -2). Therefore, analysis of this ACH pedigree suggests that the ACH locus is not linked to the NF1 locus on chromosome 17. 相似文献
19.
Nadège Presneau Valérie Laplace-Marieze Valérie Sylvain Alain Lortholary Agnès Hardouin Dominique Bernard-Gallon Y.-J. Bignon 《Human genetics》1998,103(3):334-339
A novel complex mutation consisting of a small deletion/insertion (3958del5ins4) was found in the breast cancer-1 gene (BRCA-1) in three unrelated French breast and/or ovarian cancer families. These mutations occurred at the same nucleotide position
of the 3′ end of exon 11. The wild-type sequence, CTCAG, was deleted and replaced by AGGC in the three families. The consequence
is the generation of a stop codon, TAG, resulting in a truncated protein. We propose two different mechanisms to explain the
generation of this complex mutation: (i) the simultaneous occurrence of a deletion and an insertion in a stem-loop structure
and (ii) the abortive integration of a human transposable element (Tigger 1) that deleted 5 nucleotides and inserted a 4-nucleotide “scar”, corresponding to the 5′ extremity of the transposon.
Received: 26 November 1997 / Accepted: 6 February 1998 相似文献
20.
Paolo Gasparini Leonardo D'Agruma Gian Pio de Cillis Paolo Balestrazzi Rita Mingarelli Leopoldo Zelante 《Human genetics》1996,97(4):492-495
Neurofibromatosis type 1 (NF1) of von Recklinghausen is a common autosomal dominant disorder, characterized by peripheral
neurofibromas, café-au-lait spots and Lisch nodules of the iris. The high mutation rate at the NF1 locus results in a wide
range of molecular abnormalities. We have scanned 14 different exons from the first part of the NF1 gene using the RNA-single
strand conformation polymorphism (RNA-SSCP) method in a series of 40 NF1 patients. Three novel mutations, two nonsense and
one missense, and two polymorphisms have been detected in familial cases. Genotype-phenotype correlations have been investigated,
but no particular association has been detected. After this screening, the majority of NF1 chromosomes has not yet been characterized,
confirming the difficulty in detecting the defect underlying NF1 in most families, even following extensive DNA analysis.
Received: 4 August 1995 / Revised: 19 September 1995 相似文献